TABLE 3.
Validation Cohort (n = 28) | CMA |
||||
---|---|---|---|---|---|
CDKN2A Loss | No CDKN2A Loss | Total | Sensitivity | Specificity | |
| |||||
ddPCR | |||||
CDKN2A loss | 17 | 1 | 18 | 94.4% | 90.0% |
No | 1 | 9 | 10 | ||
CDKN2A loss | |||||
Total | 18 | 10 | 28 |
Validation Cohort (n = 28) | CMA |
||||
---|---|---|---|---|---|
CDKN2A Loss | No CDKN2A Loss | Total | Sensitivity | Specificity | |
| |||||
ddPCR | |||||
CDKN2A loss | 17 | 1 | 18 | 94.4% | 90.0% |
No | 1 | 9 | 10 | ||
CDKN2A loss | |||||
Total | 18 | 10 | 28 |